Search Results Search Sort by RelevanceMost Recent State of the Art and Science Jan 2020 Making Emergency Use of Experimental Vaccines Safer Archana Asundi, MD and Nahid Bhadelia, MD How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”? AMA J Ethics. 2020;22(1):E43-49. doi: 10.1001/amajethics.2020.43. State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.
State of the Art and Science Jan 2020 Making Emergency Use of Experimental Vaccines Safer Archana Asundi, MD and Nahid Bhadelia, MD How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”? AMA J Ethics. 2020;22(1):E43-49. doi: 10.1001/amajethics.2020.43.
State of the Art and Science Aug 2020 American College of Preventive Medicine Statement on Prioritizing Prevention in Opioid Research Hunter Jackson Smith, MD, MPH, MBE, Elizabeth Salisbury-Afshar, MD, MPH, Bob Carr, MD, MPH, and Stephanie Zaza, MD, MPH Opioid use research has focused mainly on treatment and overdose responses. Clinically and ethically, these priorities should change. AMA J Ethics. 2020;22(8):E687-694. doi: 10.1001/amajethics.2020.687.